Vantage Galan 3T, MRT-3020, V9.0 with AiCE Reconstruction Processing Unit for MR

The Vantage Galan 3T, MRT-3020, V9.0 system is a diagnostic MRI device that aims to enhance image quality and streamline clinical workflows for head and body imaging. It achieves this through a 3 Tesla magnetic field and the integration of an AiCE Reconstruction Processing Unit, leveraging advanced software incorporating Deep Learning and Machine Learning for features like motion correction, high-resolution image generation from lower matrix data, and automated scan assistance.

The Vantage Galan 3T, MRT-3020, V9.0 is a 3 Tesla Magnetic Resonance Imaging (MRI) system designed for diagnostic imaging, producing cross-sectional images (transaxial, coronal, sagittal, oblique) of the head or body. It visualizes anatomic structures by mapping the spatial distribution of protons based on their nuclear magnetic resonance (NMR) properties, including proton density, T1 and T2 relaxation times, flow dynamics, and chemical shift. The system supports non-contrast enhanced imaging, such as MRA, and allows for the use of contrast agents. This V9.0 iteration incorporates an AiCE (Advanced intelligent Clear-IQ Engine) Reconstruction Processing Unit and introduces significant software and accessory enhancements, primarily leveraging Deep Learning and Machine Learning, to improve image quality, workflow efficiency, and patient experience. Key software updates include Exsper for improved 3D encoding, slice shimming for enhanced magnetic field homogeneity, and Deep Learning-based Iterative Motion Correction (IMC) to reduce motion artifacts. Free Breathing Dynamic imaging utilizes Deep Learning reconstruction for contrast-enhanced scans in patients unable to hold their breath. The Precise IQ Engine (PIQE), also Deep Learning-based, generates higher resolution images from lower matrix data, reducing ringing and improving sharpness, particularly for brain and knee imaging. NeuroLine+ employs Machine Learning for automated scan alignment. Testing confirmed these enhancements yield significant benefits: PIQE demonstrated improved image sharpness and artifact reduction while maintaining SNR; IMC effectively reduced motion artifacts and improved diagnostic confidence; Free Breathing Dynamic provided clinically acceptable liver exams; and automated tools like Auto Scan Assist and NeuroLine+ streamlined workflows. Accessory updates like the improved Tablet UX and faster reconstruction kit further augment system performance and usability.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the performance of the Deep Learning-based Precise IQ Engine (PIQE) compare to traditional reconstruction methods in terms of quantitative image metrics (e.g., SNR, CNR, spatial resolution) across a wider range of anatomical regions beyond brain and knee?; What is the computational overhead and processing time associated with the new Deep Learning features like Iterative Motion Correction (IMC) and Free Breathing Dynamic, and how might this impact clinical throughput?; Can the Iterative Motion Correction (IMC) effectively distinguish between involuntary physiological motion (e.g., respiratory, cardiac) and gross patient movement, and are there specific motion patterns where its efficacy is reduced?; For the Free Breathing Dynamic imaging, what are the specific advantages and limitations of the Deep Learning reconstruction in achieving diagnostic quality in dynamic contrast-enhanced liver studies compared to conventional breath-hold techniques or other motion compensation methods?; How do the automated features like Auto Protocol Brain Application and Auto Scan Assist adapt to atypical anatomy or unexpected pathological findings during the automated examination process?